These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

671 related items for PubMed ID: 17050773

  • 1. Differential glycosylation of polymeric and monomeric IgA: a possible role in glomerular inflammation in IgA nephropathy.
    Oortwijn BD, Roos A, Royle L, van Gijlswijk-Janssen DJ, Faber-Krol MC, Eijgenraam JW, Dwek RA, Daha MR, Rudd PM, van Kooten C.
    J Am Soc Nephrol; 2006 Dec; 17(12):3529-39. PubMed ID: 17050773
    [Abstract] [Full Text] [Related]

  • 2. Glomerular activation of the lectin pathway of complement in IgA nephropathy is associated with more severe renal disease.
    Roos A, Rastaldi MP, Calvaresi N, Oortwijn BD, Schlagwein N, van Gijlswijk-Janssen DJ, Stahl GL, Matsushita M, Fujita T, van Kooten C, Daha MR.
    J Am Soc Nephrol; 2006 Jun; 17(6):1724-34. PubMed ID: 16687629
    [Abstract] [Full Text] [Related]

  • 3. Synthesis of TNF-alpha by mesangial cells cultured with polymeric anionic IgA--role of MAPK and NF-kappaB.
    Leung JC, Tang SC, Chan LY, Chan WL, Lai KN.
    Nephrol Dial Transplant; 2008 Jan; 23(1):72-81. PubMed ID: 17898021
    [Abstract] [Full Text] [Related]

  • 4. Monomeric immunoglobulin A protects glomerulus against polymeric immunoglobulin A immune complex in experimental immunoglobulin A nephropathy.
    Chen A, Sheu LF, Ding SL, Lee WH.
    Lab Invest; 1996 Apr; 74(4):737-46. PubMed ID: 8606484
    [Abstract] [Full Text] [Related]

  • 5. Pathogenesis of IgA nephropathy.
    Feehally J, Allen AC.
    Ann Med Interne (Paris); 1999 Feb; 150(2):91-8. PubMed ID: 10392257
    [Abstract] [Full Text] [Related]

  • 6. Structural features of IgA molecules which contribute to IgA nephropathy.
    Feehally J, Allen AC.
    J Nephrol; 1999 Feb; 12(2):59-65. PubMed ID: 10378660
    [Abstract] [Full Text] [Related]

  • 7. O-glycosylation of serum IgD in IgA nephropathy.
    Smith AC, de Wolff JF, Molyneux K, Feehally J, Barratt J.
    J Am Soc Nephrol; 2006 Apr; 17(4):1192-9. PubMed ID: 16510764
    [Abstract] [Full Text] [Related]

  • 8. Glycosylation profile of differently charged IgA1 and their binding characteristics to cultured mesangial cells in IgA nephropathy.
    Leung JC, Chan LY, Tang SC, Tam PC, Fenn J, Lai KN.
    Nephron Exp Nephrol; 2007 Apr; 107(3):e107-18. PubMed ID: 17957128
    [Abstract] [Full Text] [Related]

  • 9. Different glycosylation profile of serum IgA1 in IgA nephropathy according to the glomerular basement membrane thickness: normal versus thin.
    Linossier MT, Palle S, Berthoux F.
    Am J Kidney Dis; 2003 Mar; 41(3):558-64. PubMed ID: 12612978
    [Abstract] [Full Text] [Related]

  • 10. The role of secretory IgA and complement in IgA nephropathy.
    Oortwijn BD, Eijgenraam JW, Rastaldi MP, Roos A, Daha MR, van Kooten C.
    Semin Nephrol; 2008 Jan; 28(1):58-65. PubMed ID: 18222347
    [Abstract] [Full Text] [Related]

  • 11. O-glycosylation of serum IgA1 antibodies against mucosal and systemic antigens in IgA nephropathy.
    Smith AC, Molyneux K, Feehally J, Barratt J.
    J Am Soc Nephrol; 2006 Dec; 17(12):3520-8. PubMed ID: 17093066
    [Abstract] [Full Text] [Related]

  • 12. An increased polymeric IgA level is not a prognostic marker for progressive IgA nephropathy.
    van der Boog PJ, van Kooten C, van Seggelen A, Mallat M, Klar-Mohamad N, de Fijter JW, Daha MR.
    Nephrol Dial Transplant; 2004 Oct; 19(10):2487-93. PubMed ID: 15252166
    [Abstract] [Full Text] [Related]

  • 13. The pathogenic role of IgA1 O-linked glycosylation in the pathogenesis of IgA nephropathy.
    Barratt J, Smith AC, Feehally J.
    Nephrology (Carlton); 2007 Jun; 12(3):275-84. PubMed ID: 17498123
    [Abstract] [Full Text] [Related]

  • 14. Serum under-galactosylated IgA1 is increased in Japanese patients with IgA nephropathy.
    Shimozato S, Hiki Y, Odani H, Takahashi K, Yamamoto K, Sugiyama S.
    Nephrol Dial Transplant; 2008 Jun; 23(6):1931-9. PubMed ID: 18178603
    [Abstract] [Full Text] [Related]

  • 15. Mass spectrometry analysis of IgA1 hinge region in patients with IgA nephropathy.
    Gastaldi D, Paradisi L, Baiocchi C, Medana C, Lo Duca G, Sena LM, Roccatello D.
    J Nephrol; 2007 Jun; 20(6):689-95. PubMed ID: 18046671
    [Abstract] [Full Text] [Related]

  • 16. The glycans deficiencies of macromolecular IgA1 is a contributory factor of variable pathological phenotypes of IgA nephropathy.
    Xu LX, Yan Y, Zhang JJ, Zhang Y, Zhao MH.
    Clin Exp Immunol; 2005 Dec; 142(3):569-75. PubMed ID: 16297170
    [Abstract] [Full Text] [Related]

  • 17. Binding capacity of in vitro deglycosylated IgA1 to human mesangial cells.
    Zhang JJ, Xu LX, Zhang Y, Zhao MH.
    Clin Immunol; 2006 Apr; 119(1):103-9. PubMed ID: 16442846
    [Abstract] [Full Text] [Related]

  • 18. Engagement of transferrin receptor by polymeric IgA1: evidence for a positive feedback loop involving increased receptor expression and mesangial cell proliferation in IgA nephropathy.
    Moura IC, Arcos-Fajardo M, Gdoura A, Leroy V, Sadaka C, Mahlaoui N, Lepelletier Y, Vrtovsnik F, Haddad E, Benhamou M, Monteiro RC.
    J Am Soc Nephrol; 2005 Sep; 16(9):2667-76. PubMed ID: 15987753
    [Abstract] [Full Text] [Related]

  • 19. Aberrant glycosylation of IgA1 and anti-glycan antibodies in IgA nephropathy: role of mucosal immune system.
    Novak J, Moldoveanu Z, Julian BA, Raska M, Wyatt RJ, Suzuki Y, Tomino Y, Gharavi AG, Mestecky J, Suzuki H.
    Adv Otorhinolaryngol; 2011 Sep; 72():60-3. PubMed ID: 21865691
    [Abstract] [Full Text] [Related]

  • 20. Polymeric IgA increases the synthesis of macrophage migration inhibitory factor by human mesangial cells in IgA nephropathy.
    Leung JC, Tang SC, Chan LY, Tsang AW, Lan HY, Lai KN.
    Nephrol Dial Transplant; 2003 Jan; 18(1):36-45. PubMed ID: 12480958
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 34.